Press release
Global Implantable Pump Catheter Market Projected to Experience Major Revenue Boost during the Period 2018-2028 / Key Players North America (U.S., Canada), Latin America (Mexico. Brazil), Western Europe (Germany, Italy, France, U.K, Spain), Eastern Europe
Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=861
Implantable pump catheter is expected to witness high demand on the backdrop of increased prevalence of pulmonary arterial hypertension (PAH). Implantable pump catheter facilitates catheter implantation during treatment of PAH-affected patients and automates the administration of doses, and have emerged as a boon for patients with PAH as they have witnessed significant improvement in quality of life post-treatment.
Significant reduction in the rate of blood stream infections (BSIs) as site infections, in contrary to that with apropos of external IV systems, is a key benefit of implantable pump catheter which is increasing its palpability in PAH treatment. Implantable pump catheter also aids in eliminating chronic treprostinil-induced, SC administration-associated infusion site pain, which in turn has driven its demand among hospitals and ambulatory surgical centers (ASCs).
The U.S. Food and Drug Administration has recently approved the SynchroMed II myPTM Personal Therapy Manager, an implantable pump catheter device that offers patient-managed pain control. This implantable pump catheter provides patients with various chronic pain that include diabetes, cancer and heart disease, for managing unpredictable pain via delivering on-demand dosages within confines set by their provider.
A typical infusion system consists of two implanted components: a pump and a catheter. Catheter is a thin, flexible tube that connects to implantable pump through catheter port. The catheter is made of radiopaque silicone with enhanced radiopacity at the distal tip. Whereas, the pump delivers medication through the catheter to a specific site in body where it can have the best effect. An implantable pump comprises housing, a drug reservoir, a metering device, and a catheter access port. The catheter access port is guarded by a denial device which is configured to prevent insertion of a needle into the catheter access port. Whereas, the drug reservoir is coupled to the housing and has a reservoir outlet. This reservoir outlet is coupled to a metering device that has its own metered outlet. The catheter access port is fluidly coupled to the metered outlet and is configured for receiving a needle to infuse drug directly into a catheter.
The implantable pump catheter and the suture less connector are part of the Medtronic Implantable System for Remodulin that store and deliver Remodulin (treprostinil) injection into the bloodstream. The catheter connects to the pump catheter port. The pump is anchored in the pump pocket using the suture loops located on the outside of the pump.
To know more about the Implantable Pump Catheter Market Visit the link- https://www.factmr.com/report/861/implantable-pump-catheter-market
Implantable Pump Catheter Market: Drivers and Restraints
Primary factors driving implantable pump catheter market include growing need for safe and effective guiding technology for PAH. Besides, rising prevalence of pulmonary arterial hypertension disease, increasing adoption of Remodulin for pulmonary arterial hypertension treatment, increase in healthcare spending, and rise in awareness, creating high potential growth opportunities for upcoming players of implantable pump and catheter. However, unawareness towards the procedure, high cost of treatment and device, and lack of reimbursement in some under developing countries are the factor limiting the growth of the global implantable pump catheter market.
Besides, possible system complications such as tissue damage or a loss of or change in therapy, might lead to a return of underlying symptoms, drug withdrawal symptoms, serious injury, or death and might require surgery to replace or remove the pump, catheter, or catheter fragment. The pump, catheter, or catheter fragment could migrate within the body or erode through the skin. Moreover, there could be undesirable changes in therapy, possibly related to cellular changes around the tip of the catheter. Apart from this, the catheter could leak, tear, or become disconnected, resulting in delivery of medication into the area under the skin where the pump is implanted or along the catheter path. Also, the catheter could kink or become blocked resulting in no delivery of medication.
The global market for echogenic catheters is highly consolidated, and dominated by only one player in the global space. Medtronic is the only player currently offering implantable pump catheter for Remodulin for the patient suffering from pulmonary arterial hypertension. This device has been granted on December 22, 2017, after eight years of study, by the FDA. The authority granted pre-market approval (PMA) to the fully implantable system for Remodulin. This groundbreaking pump and catheter system allows patients to benefit from Remodulin while minimizing the inconvenience and risks associated with having an external intravenous catheter.
Implantable Pump Catheter Market: Regional Wise Outlook
Geographically, the global implantable pump catheter market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America and Europe is expected to be the leader in global implantable pump catheter market owing to concentration of key market players, and early adoption in the region. The market in Asia Pacific excluding Japan, China and MEA are expected to show sluggish growth during the forecast period. However, Japan is expected to show high growth owing to their high per person healthcare spending.
Implantable Pump Catheter Market: Key Players
Medtronic is the only player operating in this market. Examples of some of the major players in the global implantable pump catheter market are Medtronic, etc. Medtronic offers implantable pump along with catheter.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=861
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Implantable Pump Catheter Market Projected to Experience Major Revenue Boost during the Period 2018-2028 / Key Players North America (U.S., Canada), Latin America (Mexico. Brazil), Western Europe (Germany, Italy, France, U.K, Spain), Eastern Europe here
News-ID: 1452319 • Views: …
More Releases from Fact.MR
Maleic Anhydride Market: Anticipated Growth to US$ 4.1 Billion | Fact.MR
A recent Fact.MR analysis projects that the global market for Maleic Anhydride will expand at a compound annual growth rate (CAGR) of 3.4% between 2022 and 2032. The industry is predicted to produce a dollar opportunity of US$ 1.2 billion throughout the aforementioned forecast period, with a closing valuation of US$ 4.1 billion. The market for maleic anhydride expanded at a 4.0% CAGR between 2015 and 2021. The sector is…
Motion Control Market Anticipated to Achieve US$ 35.52 Billion Valuation by 2033
According to the most recent industry report by market research and competitive intelligence source Fact.MR, the global Motion Control Market is expected to reach US$ 35.52 billion by 2033, growing at a 5.1% CAGR from 2023 to 2033. the market is growing gradually due to a number of important variables. There is a strong desire for industrialization and automation in many different businesses. Businesses are searching for methods to boost…
Benzoic Acid Market: Approaching US$ 1.6 Billion by 2032 | Fact.MR
According to a recently released Fact.MR analysis, the Benzoic Acid Market is expected to generate revenues of US$ 1 billion in 2021 and rise at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2032. It is anticipated that the market will be valued US$ 1.6 billion by the end of 2032. the primary end-use application for benzoic acid is benzoates, whose use is increasing due to the…
Newborn Metabolic Screening Market to US$ 857.4 Million by 2034
According to estimates, the Newborn Metabolic Screening Market will be valued US$ 355.1 million by 2024. With a predicted growth rate of 9.2% between 2024 and 2034, the need for newborn metabolic screening is expected to rise in a positive manner. By 2034, the market is expected to be worth more than US$ 857.4 million. the market is growing mainly because parents and healthcare professionals are becoming more aware of…
More Releases for Implantable
Nanotechnology in Medical Devices Market 2028 by Implantable Materials, Active I …
The Insight Partners analysts forecasts the latest report on “Global Nanotechnology in Medical Devices Market (Covid-19) Impact and Analysis by 2028”, according to report; The Nanotechnology in Medical Devices Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Nanotechnology in Medical Devices Market.
The study…
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
The Global Nano Medical Devices Market is expected to grow at a CAGR of 10.29% during Forecasted Period 2017-2023.
Nanomedical Devices Market - Segmentation
The global Nanomedical Devices Market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular…
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
Nanomedical Devices Market - Segmentation
The global nanomedical devices market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular diseases neurological diseases, and other. With regards to end users, the market has been segmented into clinics, hospitals,…
Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025.
For In depth Information Get…
Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantabl …
The Global Active Implantable Medical Devices Market by product type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 16,721.2 million in 2016 and is projected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), as highlighted in a new…
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of…
